Skip to content
Screener

CalAmp CAMP EPS (Diluted)

EPS (Diluted) at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$0.69-199%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$0.79-142%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$1.19-58.7%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$1.71+456%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$0.05+54.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-$0.13-44.4%

Other financials

Income statement

See full
Revenue$1.8M+18.8%
Operating income-$13.4M-2.7%
Net income-$33.5M-166%

Balance sheet

See full
Cash & equivalents$88.0M+116%
Total debt$2.4M-66.8%
Total equity-$693.0K-102%
Total assets$93.4M+82.2%

Cash flow

See full
Operating cash flow-$12.7M-22.7%
CapEx$129.0K
Free cash flow-$12.8M-23.9%

Valuation

See full
Market cap$263.56M+766%
Enterprise value$177.91M-5,871%
P/S62.5×+52.4×

Profitability

See full
Operating margin-1,254.2%-287pp
Net margin-2,543.7%+2,321pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio4.7×-0.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: CalAmp’s 10-Q, filed August 13, 2026.

Filed
Aug 13, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-056760
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other (expense) income(27)(12)(9)67
Total other (expense) income, net(20,150)441(25,410)1,108
Net loss$(33,530)$(12,587)$(51,861)$(25,020)
Net loss per share attributable to common stockholders, basic and diluted$(0.58)$(0.62)$(0.90)$(1.24)
Weighted-average shares of common stock outstanding, basic and diluted57,929,66220,159,66657,926,68520,155,161
Net loss attributable to common stockholders$(33,530)$(12,587)$(51,861)$(25,020)
Other comprehensive income (loss)
Total comprehensive loss$(33,530)$(12,587)$(51,861)$(25,020)

Item 1. Financial Statements (Unaudited)

FAQ

What is CalAmp's EPS (diluted)?
CalAmp (CAMP) reported EPS (diluted) of -$0.58 in Q2 2026.
How has CalAmp's EPS (diluted) changed year-over-year?
CalAmp's EPS (diluted) increased by 6.5% year-over-year, from -$0.62 to -$0.58.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about CalAmp's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude